Rapid and quantitative detection of C-reactive protein using quantum dots and immunochromatographic test strips

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 5619-5626

  Cheng, Xianglin ^a   Pu, Xu ^b   Jun, Pen ^c   Zhu, Xiaobo ^c   Chen, Ming ^a,d  

^a YANGTZE UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

C reactive protein; Fluorescence point of care test; Immunochromatographic test; Quantum dots

Indexed keywords

C REACTIVE PROTEIN; FLUORESCENT DYE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PYROXYLIN; QUANTUM DOT;

ACCURACY; ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY ANALYZER; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MALE; POINT OF CARE TESTING; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAPID TEST; SEMICONDUCTOR; SENSITIVITY ANALYSIS; TEST STRIP; VERY ELDERLY; CHEMISTRY; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; QUANTUM DOTS; YOUNG ADULT;

EID: 84914674381     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S74751     Document Type: Article

References (22)

1. Firestein GS. A biomarker by any other name. Nat Clin Pract Rheumatol. 2006;2(12):635–638.
2. Nwankire CE, Czugala M, Burger R, et al. A portable centrifugal analyser for liver function screening. Biosens Bioelectron. 2014;56(1): 352–358.
3. You DJ, Park TS, Yoon JY. Cell-phone-based measurement of TSH using Mie scatter optimized lateral flow assays. Biosens Bioelectron. 2013; 40(1):180–185.
4. Liang AH, Huang YJ, Jiang ZL. A rapid and sensitive immunoresonance scattering spectral assay for microalbumin. Clin Chim Acta. 2007;383(1–2): 73–77.
5. Gosling JP. A decade of development in immunoassay methodology. Clin Chem. 1990;36(3):1408–1427.
6. Von Lode P. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin Biochem. 2005;38(7): 591–606.
7. Ming C, Wei X, Biao A, et al. Sensitivity assessment of rapid influenza diagnostic tests for the detection of the 2009 pandemic influenza a (H1N1) virus in clinical specimens. LabMedicine. 2010;41(12): 731–734.
8. Zhu J, Zou N, Zhu D, et al. Simultaneous detection of high-sensitivity cardiac troponin I and myoglobin by modified sandwich lateral flow immunoassay: proof of principle. Clin Chem. 2011;57(12):1732–1738.
9. Gordon J, Michel G. Analytical sensitivity limits for lateral flow immunoassays. Clin Chem. 2008;54(10):1250–1251.
10. Oh SW, Kim YM, Kim HJ, et al. Point-of-care fluorescence immunoassay for prostate specific antigen. Clin Chim Acta. 2009;406(1–2):18–22.
11. Alivisatos AP. Semiconductor clusters, nanocrystals, and quantum dots. Science. 1996;271(5251):933–997.
12. Kilina S, Velizhanin KA, Ivanov S. Surface ligands increase photoexcitation relaxation rates in CdSe quantum dots. ACS Nano. 2012;6(7): 6515–6524.
13. Li Z, Wang Y, Wang J, et al. Rapid and sensitive detection of protein biomarker using a portable fluorescence biosensor based on quantum dots and a lateral flow test strip. Anal Chem. 2010;82(16):7008–7014.
14. Yang Q, Gong X, Song T, et al. Quantum dot-based immunochromatography test strip for rapid, quantitative and sensitive detection of alpha fetoprotein. Biosens Bioelectron. 2011;30(1):145–150.
15. Tulek B, Koylu H, Kanat F, Arslan U, Ozer F. Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients. Contemp Oncol (Pozn). 2013;17(1):68–72.
16. Ramamoorthy RD, Nallasamy V, Reddy R, Esther N, Maruthappan Y. A review of C-reactive protein: a diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci. 2012;4 Suppl 2:422–426.
17. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207.
18. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab. 2002;22(4):1399–1419.
19. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–1565.
20. Roberts WL, Sedrick R, Moulton L, et al. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem. 2000;46(4):461–468.
21. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem. 2001;47(3): 418–425.
22. Ahn JS, Choi S, Jang SH, et al. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clin Chim Acta. 2003;332(2):51–59.